Structure

Physi-Chem Properties

Molecular Weight:  478.22
Volume:  472.66
LogP:  1.771
LogD:  1.389
LogS:  -3.633
# Rotatable Bonds:  5
TPSA:  128.59
# H-Bond Aceptor:  9
# H-Bond Donor:  2
# Rings:  4
# Heavy Atoms:  9

MedChem Properties

QED Drug-Likeness Score:  0.461
Synthetic Accessibility Score:  5.387
Fsp3:  0.72
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.091
MDCK Permeability:  6.480895535787567e-05
Pgp-inhibitor:  0.998
Pgp-substrate:  0.004
Human Intestinal Absorption (HIA):  0.14
20% Bioavailability (F20%):  0.25
30% Bioavailability (F30%):  0.985

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.661
Plasma Protein Binding (PPB):  48.9070930480957%
Volume Distribution (VD):  1.264
Pgp-substrate:  49.436031341552734%

ADMET: Metabolism

CYP1A2-inhibitor:  0.02
CYP1A2-substrate:  0.073
CYP2C19-inhibitor:  0.028
CYP2C19-substrate:  0.53
CYP2C9-inhibitor:  0.062
CYP2C9-substrate:  0.03
CYP2D6-inhibitor:  0.009
CYP2D6-substrate:  0.08
CYP3A4-inhibitor:  0.444
CYP3A4-substrate:  0.402

ADMET: Excretion

Clearance (CL):  2.625
Half-life (T1/2):  0.428

ADMET: Toxicity

hERG Blockers:  0.41
Human Hepatotoxicity (H-HT):  0.548
Drug-inuced Liver Injury (DILI):  0.429
AMES Toxicity:  0.854
Rat Oral Acute Toxicity:  0.908
Maximum Recommended Daily Dose:  0.196
Skin Sensitization:  0.485
Carcinogencity:  0.673
Eye Corrosion:  0.007
Eye Irritation:  0.011
Respiratory Toxicity:  0.954

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC177047

Natural Product ID:  NPC177047
Common Name*:   1Alpha,6Alpha-Diacetoxy-5Alpha,7Beta-Dihydroxy-12Alpha-Methoxycassa-14(17),13(15)-Dien-16,12-Olide
IUPAC Name:   [(1S,4aR,5S,6R,6aR,10aR,11aS,11bS)-5-acetyloxy-4a,6-dihydroxy-10a-methoxy-4,4,11b-trimethyl-7-methylidene-9-oxo-1,2,3,5,6,6a,11,11a-octahydronaphtho[2,1-f][1]benzofuran-1-yl] acetate
Synonyms:  
Standard InCHIKey:  FZORVJMAWWTYLA-JLHWGCSWSA-N
Standard InCHI:  InChI=1S/C25H34O9/c1-12-15-10-18(28)34-24(15,31-7)11-16-19(12)20(29)21(33-14(3)27)25(30)22(4,5)9-8-17(23(16,25)6)32-13(2)26/h10,16-17,19-21,29-30H,1,8-9,11H2,2-7H3/t16-,17-,19-,20+,21-,23-,24+,25+/m0/s1
SMILES:  CO[C@@]12OC(=O)C=C2C(=C)[C@H]2[C@H](C1)[C@@]1(C)[C@H](CCC([C@@]1([C@H]([C@@H]2O)OC(=O)C)O)(C)C)OC(=O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2386708
PubChem CID:   71725698
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0001634] Naphthofurans

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO14392 Caesalpinia minax Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[11678648]
NPO14392 Caesalpinia minax Species Fabaceae Eukaryota Seeds n.a. n.a. PMID[23806110]
NPO14392 Caesalpinia minax Species Fabaceae Eukaryota Seeds n.a. n.a. PMID[24303808]
NPO14392 Caesalpinia minax Species Fabaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO14392 Caesalpinia minax Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO14392 Caesalpinia minax Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT83 Cell Line MCF7 Homo sapiens IC50 > 50000.0 nM PMID[482726]
NPT65 Cell Line HepG2 Homo sapiens IC50 = 38900.0 nM PMID[482726]
NPT81 Cell Line A549 Homo sapiens IC50 > 50000.0 nM PMID[482726]
NPT196 Cell Line AGS Homo sapiens IC50 > 50000.0 nM PMID[482726]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC177047 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9412 High Similarity NPC51719
0.9406 High Similarity NPC45897
0.9406 High Similarity NPC281378
0.932 High Similarity NPC471205
0.932 High Similarity NPC122816
0.9048 High Similarity NPC50124
0.902 High Similarity NPC472554
0.8962 High Similarity NPC206618
0.8932 High Similarity NPC472552
0.8932 High Similarity NPC11956
0.8922 High Similarity NPC38855
0.8868 High Similarity NPC38948
0.8857 High Similarity NPC471206
0.8846 High Similarity NPC23584
0.8835 High Similarity NPC11974
0.875 High Similarity NPC268326
0.875 High Similarity NPC153085
0.8739 High Similarity NPC34390
0.8739 High Similarity NPC196429
0.8739 High Similarity NPC77319
0.8739 High Similarity NPC158344
0.8739 High Similarity NPC471351
0.8739 High Similarity NPC471353
0.8739 High Similarity NPC87250
0.8739 High Similarity NPC309034
0.8739 High Similarity NPC471354
0.8739 High Similarity NPC244402
0.8739 High Similarity NPC471355
0.8739 High Similarity NPC152615
0.8739 High Similarity NPC157376
0.8739 High Similarity NPC84987
0.8739 High Similarity NPC99728
0.8739 High Similarity NPC50305
0.8739 High Similarity NPC474418
0.8739 High Similarity NPC473852
0.8739 High Similarity NPC243196
0.8739 High Similarity NPC142066
0.8739 High Similarity NPC27507
0.8716 High Similarity NPC317460
0.8716 High Similarity NPC328074
0.8716 High Similarity NPC470025
0.8716 High Similarity NPC321272
0.8713 High Similarity NPC276110
0.8704 High Similarity NPC316708
0.8692 High Similarity NPC181994
0.8673 High Similarity NPC475136
0.8673 High Similarity NPC474466
0.8667 High Similarity NPC120009
0.8661 High Similarity NPC83287
0.8649 High Similarity NPC199428
0.8649 High Similarity NPC99620
0.8649 High Similarity NPC5311
0.8649 High Similarity NPC193382
0.8649 High Similarity NPC310341
0.8641 High Similarity NPC278673
0.8636 High Similarity NPC470027
0.8624 High Similarity NPC470026
0.8624 High Similarity NPC17791
0.8611 High Similarity NPC316974
0.8598 High Similarity NPC475074
0.8598 High Similarity NPC473586
0.8584 High Similarity NPC329905
0.8584 High Similarity NPC304260
0.8584 High Similarity NPC5883
0.8584 High Similarity NPC44899
0.8584 High Similarity NPC29639
0.8571 High Similarity NPC203862
0.8571 High Similarity NPC121423
0.8571 High Similarity NPC93883
0.8559 High Similarity NPC69576
0.8559 High Similarity NPC471633
0.8559 High Similarity NPC31354
0.8559 High Similarity NPC84949
0.8544 High Similarity NPC51499
0.8519 High Similarity NPC128795
0.8519 High Similarity NPC135015
0.8519 High Similarity NPC48548
0.8519 High Similarity NPC217921
0.8519 High Similarity NPC311223
0.8519 High Similarity NPC475263
0.8509 High Similarity NPC475629
0.8509 High Similarity NPC475556
0.8505 High Similarity NPC82251
0.8505 High Similarity NPC218158
0.8491 Intermediate Similarity NPC474124
0.8491 Intermediate Similarity NPC474822
0.8491 Intermediate Similarity NPC474575
0.8482 Intermediate Similarity NPC471816
0.8476 Intermediate Similarity NPC475617
0.8462 Intermediate Similarity NPC275086
0.8462 Intermediate Similarity NPC325229
0.844 Intermediate Similarity NPC475030
0.844 Intermediate Similarity NPC40728
0.8435 Intermediate Similarity NPC231518
0.8435 Intermediate Similarity NPC314535
0.8435 Intermediate Similarity NPC475219
0.8435 Intermediate Similarity NPC173555
0.8435 Intermediate Similarity NPC233500
0.8431 Intermediate Similarity NPC105490
0.8426 Intermediate Similarity NPC125423
0.8426 Intermediate Similarity NPC187435
0.8426 Intermediate Similarity NPC67321
0.8426 Intermediate Similarity NPC88013
0.8426 Intermediate Similarity NPC109376
0.8421 Intermediate Similarity NPC292467
0.8421 Intermediate Similarity NPC55532
0.8421 Intermediate Similarity NPC30483
0.8421 Intermediate Similarity NPC470914
0.8421 Intermediate Similarity NPC32177
0.8421 Intermediate Similarity NPC236973
0.8421 Intermediate Similarity NPC469756
0.8421 Intermediate Similarity NPC470897
0.8411 Intermediate Similarity NPC473543
0.8407 Intermediate Similarity NPC290693
0.8396 Intermediate Similarity NPC476471
0.8396 Intermediate Similarity NPC475344
0.8396 Intermediate Similarity NPC472815
0.8396 Intermediate Similarity NPC470571
0.8381 Intermediate Similarity NPC324841
0.8364 Intermediate Similarity NPC119550
0.8362 Intermediate Similarity NPC196130
0.8362 Intermediate Similarity NPC471082
0.8362 Intermediate Similarity NPC115349
0.8362 Intermediate Similarity NPC193893
0.8362 Intermediate Similarity NPC264336
0.8349 Intermediate Similarity NPC88701
0.8349 Intermediate Similarity NPC224660
0.8349 Intermediate Similarity NPC470024
0.8348 Intermediate Similarity NPC72260
0.8333 Intermediate Similarity NPC172867
0.8333 Intermediate Similarity NPC119855
0.8333 Intermediate Similarity NPC239961
0.8333 Intermediate Similarity NPC473828
0.8333 Intermediate Similarity NPC110022
0.8333 Intermediate Similarity NPC220217
0.8333 Intermediate Similarity NPC218093
0.8333 Intermediate Similarity NPC473617
0.8333 Intermediate Similarity NPC186668
0.8333 Intermediate Similarity NPC53555
0.8333 Intermediate Similarity NPC88349
0.8333 Intermediate Similarity NPC7349
0.8319 Intermediate Similarity NPC207637
0.8318 Intermediate Similarity NPC473523
0.8318 Intermediate Similarity NPC187302
0.8318 Intermediate Similarity NPC189588
0.8318 Intermediate Similarity NPC97487
0.8318 Intermediate Similarity NPC10232
0.8318 Intermediate Similarity NPC472821
0.8318 Intermediate Similarity NPC165608
0.8318 Intermediate Similarity NPC196471
0.8304 Intermediate Similarity NPC264153
0.8302 Intermediate Similarity NPC477717
0.8302 Intermediate Similarity NPC198992
0.8291 Intermediate Similarity NPC308262
0.8291 Intermediate Similarity NPC208193
0.8291 Intermediate Similarity NPC117445
0.8276 Intermediate Similarity NPC120390
0.8276 Intermediate Similarity NPC475590
0.8276 Intermediate Similarity NPC475419
0.8276 Intermediate Similarity NPC474908
0.8276 Intermediate Similarity NPC40749
0.8269 Intermediate Similarity NPC165632
0.8261 Intermediate Similarity NPC219656
0.8261 Intermediate Similarity NPC291820
0.8261 Intermediate Similarity NPC81222
0.8257 Intermediate Similarity NPC472820
0.8257 Intermediate Similarity NPC472390
0.8246 Intermediate Similarity NPC473968
0.8246 Intermediate Similarity NPC474483
0.8241 Intermediate Similarity NPC264867
0.8241 Intermediate Similarity NPC471937
0.8241 Intermediate Similarity NPC473207
0.8241 Intermediate Similarity NPC81567
0.8241 Intermediate Similarity NPC201880
0.8241 Intermediate Similarity NPC470321
0.8235 Intermediate Similarity NPC329842
0.8224 Intermediate Similarity NPC475038
0.8224 Intermediate Similarity NPC109195
0.8224 Intermediate Similarity NPC476081
0.8224 Intermediate Similarity NPC470053
0.8214 Intermediate Similarity NPC470063
0.8214 Intermediate Similarity NPC473125
0.8208 Intermediate Similarity NPC474190
0.8208 Intermediate Similarity NPC477972
0.8208 Intermediate Similarity NPC473510
0.8208 Intermediate Similarity NPC161527
0.8208 Intermediate Similarity NPC219285
0.8208 Intermediate Similarity NPC230546
0.8208 Intermediate Similarity NPC254567
0.8208 Intermediate Similarity NPC477971
0.8208 Intermediate Similarity NPC477716
0.8208 Intermediate Similarity NPC16601
0.8208 Intermediate Similarity NPC474571
0.8208 Intermediate Similarity NPC477968
0.8208 Intermediate Similarity NPC228251
0.8208 Intermediate Similarity NPC477721
0.8208 Intermediate Similarity NPC188968
0.8208 Intermediate Similarity NPC20113
0.8205 Intermediate Similarity NPC74259
0.8205 Intermediate Similarity NPC474423

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC177047 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.875 High Similarity NPD7516 Approved
0.8661 High Similarity NPD7328 Approved
0.8661 High Similarity NPD7327 Approved
0.8435 Intermediate Similarity NPD8296 Approved
0.8435 Intermediate Similarity NPD8335 Approved
0.8435 Intermediate Similarity NPD8378 Approved
0.8435 Intermediate Similarity NPD8379 Approved
0.8435 Intermediate Similarity NPD8033 Approved
0.8435 Intermediate Similarity NPD8380 Approved
0.8348 Intermediate Similarity NPD8294 Approved
0.8348 Intermediate Similarity NPD8377 Approved
0.8182 Intermediate Similarity NPD6686 Approved
0.812 Intermediate Similarity NPD7503 Approved
0.8 Intermediate Similarity NPD7507 Approved
0.7951 Intermediate Similarity NPD7319 Approved
0.7946 Intermediate Similarity NPD4061 Clinical (unspecified phase)
0.7944 Intermediate Similarity NPD7638 Approved
0.787 Intermediate Similarity NPD7639 Approved
0.787 Intermediate Similarity NPD7640 Approved
0.7798 Intermediate Similarity NPD5344 Discontinued
0.7719 Intermediate Similarity NPD5955 Clinical (unspecified phase)
0.7706 Intermediate Similarity NPD6648 Approved
0.7615 Intermediate Similarity NPD4225 Approved
0.7456 Intermediate Similarity NPD5954 Clinical (unspecified phase)
0.7373 Intermediate Similarity NPD8133 Approved
0.7333 Intermediate Similarity NPD7524 Approved
0.7297 Intermediate Similarity NPD8029 Clinical (unspecified phase)
0.729 Intermediate Similarity NPD7838 Discovery
0.7257 Intermediate Similarity NPD7632 Discontinued
0.719 Intermediate Similarity NPD7115 Discovery
0.7179 Intermediate Similarity NPD8132 Clinical (unspecified phase)
0.7155 Intermediate Similarity NPD6412 Phase 2
0.712 Intermediate Similarity NPD8328 Phase 3
0.7097 Intermediate Similarity NPD8515 Approved
0.7097 Intermediate Similarity NPD8513 Phase 3
0.7097 Intermediate Similarity NPD8516 Approved
0.7097 Intermediate Similarity NPD8517 Approved
0.7094 Intermediate Similarity NPD5345 Clinical (unspecified phase)
0.7048 Intermediate Similarity NPD7338 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD6882 Approved
0.6972 Remote Similarity NPD46 Approved
0.6972 Remote Similarity NPD6698 Approved
0.6952 Remote Similarity NPD6695 Phase 3
0.6929 Remote Similarity NPD7492 Approved
0.6911 Remote Similarity NPD8295 Clinical (unspecified phase)
0.6911 Remote Similarity NPD6009 Approved
0.6909 Remote Similarity NPD7637 Suspended
0.6906 Remote Similarity NPD7625 Phase 1
0.6899 Remote Similarity NPD7736 Approved
0.6887 Remote Similarity NPD6400 Clinical (unspecified phase)
0.688 Remote Similarity NPD6319 Approved
0.688 Remote Similarity NPD6054 Approved
0.688 Remote Similarity NPD6059 Approved
0.6875 Remote Similarity NPD6616 Approved
0.686 Remote Similarity NPD8297 Approved
0.6827 Remote Similarity NPD7525 Registered
0.6822 Remote Similarity NPD8293 Discontinued
0.6822 Remote Similarity NPD7078 Approved
0.6822 Remote Similarity NPD8074 Phase 3
0.6803 Remote Similarity NPD4632 Approved
0.6786 Remote Similarity NPD7748 Approved
0.678 Remote Similarity NPD6402 Approved
0.678 Remote Similarity NPD5739 Approved
0.678 Remote Similarity NPD7128 Approved
0.678 Remote Similarity NPD6675 Approved
0.6777 Remote Similarity NPD8413 Clinical (unspecified phase)
0.6772 Remote Similarity NPD6370 Approved
0.6757 Remote Similarity NPD7515 Phase 2
0.6754 Remote Similarity NPD7902 Approved
0.675 Remote Similarity NPD6373 Approved
0.675 Remote Similarity NPD6372 Approved
0.6697 Remote Similarity NPD7750 Discontinued
0.6693 Remote Similarity NPD6015 Approved
0.6693 Remote Similarity NPD6016 Approved
0.6667 Remote Similarity NPD6930 Phase 2
0.6667 Remote Similarity NPD6899 Approved
0.6667 Remote Similarity NPD7320 Approved
0.6667 Remote Similarity NPD6931 Approved
0.6667 Remote Similarity NPD6881 Approved
0.6641 Remote Similarity NPD5988 Approved
0.6639 Remote Similarity NPD6649 Approved
0.6639 Remote Similarity NPD6650 Approved
0.6585 Remote Similarity NPD6053 Discontinued
0.6583 Remote Similarity NPD5697 Approved
0.6583 Remote Similarity NPD5701 Approved
0.6581 Remote Similarity NPD4159 Approved
0.6577 Remote Similarity NPD6051 Approved
0.6571 Remote Similarity NPD6929 Approved
0.6571 Remote Similarity NPD7645 Phase 2
0.6562 Remote Similarity NPD6921 Approved
0.6557 Remote Similarity NPD6883 Approved
0.6557 Remote Similarity NPD7102 Approved
0.6557 Remote Similarity NPD6371 Approved
0.6557 Remote Similarity NPD7290 Approved
0.6549 Remote Similarity NPD6399 Phase 3
0.6542 Remote Similarity NPD4752 Clinical (unspecified phase)
0.6518 Remote Similarity NPD3168 Discontinued
0.6509 Remote Similarity NPD7332 Phase 2
0.6509 Remote Similarity NPD7514 Phase 3
0.6504 Remote Similarity NPD6869 Approved
0.6504 Remote Similarity NPD6617 Approved
0.6504 Remote Similarity NPD6847 Approved
0.6504 Remote Similarity NPD8130 Phase 1
0.65 Remote Similarity NPD6008 Approved
0.6491 Remote Similarity NPD7901 Clinical (unspecified phase)
0.6491 Remote Similarity NPD7900 Approved
0.6475 Remote Similarity NPD6013 Approved
0.6475 Remote Similarity NPD6012 Approved
0.6475 Remote Similarity NPD6014 Approved
0.6466 Remote Similarity NPD6083 Phase 2
0.6466 Remote Similarity NPD6084 Phase 2
0.6462 Remote Similarity NPD7604 Phase 2
0.6462 Remote Similarity NPD6067 Discontinued
0.646 Remote Similarity NPD7087 Discontinued
0.646 Remote Similarity NPD7983 Approved
0.6446 Remote Similarity NPD7899 Clinical (unspecified phase)
0.6442 Remote Similarity NPD6933 Approved
0.6434 Remote Similarity NPD5983 Phase 2
0.6404 Remote Similarity NPD5778 Approved
0.6404 Remote Similarity NPD5779 Approved
0.6393 Remote Similarity NPD6011 Approved
0.6391 Remote Similarity NPD6033 Approved
0.6389 Remote Similarity NPD7274 Clinical (unspecified phase)
0.6381 Remote Similarity NPD5776 Phase 2
0.6381 Remote Similarity NPD6925 Approved
0.6381 Remote Similarity NPD6932 Approved
0.6371 Remote Similarity NPD6401 Clinical (unspecified phase)
0.637 Remote Similarity NPD7260 Phase 2
0.6364 Remote Similarity NPD6640 Phase 3
0.6364 Remote Similarity NPD6893 Approved
0.6364 Remote Similarity NPD6336 Discontinued
0.6325 Remote Similarity NPD4755 Approved
0.6321 Remote Similarity NPD7145 Approved
0.6316 Remote Similarity NPD8034 Phase 2
0.6316 Remote Similarity NPD6411 Approved
0.6316 Remote Similarity NPD8035 Phase 2
0.6306 Remote Similarity NPD3618 Phase 1
0.6296 Remote Similarity NPD6898 Phase 1
0.6296 Remote Similarity NPD6902 Approved
0.629 Remote Similarity NPD4634 Approved
0.6283 Remote Similarity NPD5328 Approved
0.6275 Remote Similarity NPD7532 Clinical (unspecified phase)
0.6262 Remote Similarity NPD6683 Phase 2
0.6261 Remote Similarity NPD4202 Approved
0.626 Remote Similarity NPD5126 Approved
0.626 Remote Similarity NPD5125 Phase 3
0.625 Remote Similarity NPD6926 Approved
0.625 Remote Similarity NPD6924 Approved
0.625 Remote Similarity NPD5211 Phase 2
0.625 Remote Similarity NPD4751 Clinical (unspecified phase)
0.6218 Remote Similarity NPD5286 Approved
0.6218 Remote Similarity NPD4700 Approved
0.6218 Remote Similarity NPD4696 Approved
0.6218 Remote Similarity NPD5285 Approved
0.6216 Remote Similarity NPD7520 Clinical (unspecified phase)
0.6204 Remote Similarity NPD7509 Discontinued
0.6195 Remote Similarity NPD7513 Clinical (unspecified phase)
0.619 Remote Similarity NPD7339 Approved
0.619 Remote Similarity NPD6942 Approved
0.6174 Remote Similarity NPD6079 Approved
0.6172 Remote Similarity NPD6274 Approved
0.6161 Remote Similarity NPD6684 Approved
0.6161 Remote Similarity NPD6409 Approved
0.6161 Remote Similarity NPD5330 Approved
0.6161 Remote Similarity NPD7334 Approved
0.6161 Remote Similarity NPD7521 Approved
0.6161 Remote Similarity NPD7146 Approved
0.6154 Remote Similarity NPD5695 Phase 3
0.6154 Remote Similarity NPD7101 Approved
0.6154 Remote Similarity NPD7100 Approved
0.6148 Remote Similarity NPD5141 Approved
0.6143 Remote Similarity NPD7966 Clinical (unspecified phase)
0.614 Remote Similarity NPD7285 Clinical (unspecified phase)
0.614 Remote Similarity NPD6101 Approved
0.614 Remote Similarity NPD5764 Clinical (unspecified phase)
0.6134 Remote Similarity NPD5696 Approved
0.6132 Remote Similarity NPD3701 Clinical (unspecified phase)
0.6126 Remote Similarity NPD4786 Approved
0.6121 Remote Similarity NPD8171 Discontinued
0.6116 Remote Similarity NPD5226 Approved
0.6116 Remote Similarity NPD4633 Approved
0.6116 Remote Similarity NPD5224 Approved
0.6116 Remote Similarity NPD5225 Approved
0.6107 Remote Similarity NPD7741 Discontinued
0.6098 Remote Similarity NPD5357 Phase 1
0.6098 Remote Similarity NPD4767 Approved
0.6098 Remote Similarity NPD4768 Approved
0.6091 Remote Similarity NPD3667 Approved
0.609 Remote Similarity NPD7829 Approved
0.609 Remote Similarity NPD7830 Approved
0.6087 Remote Similarity NPD6845 Suspended
0.6087 Remote Similarity NPD8470 Clinical (unspecified phase)
0.6077 Remote Similarity NPD6335 Approved
0.6071 Remote Similarity NPD1694 Approved
0.6066 Remote Similarity NPD5174 Approved
0.6066 Remote Similarity NPD5175 Approved
0.6061 Remote Similarity NPD6909 Approved
0.6061 Remote Similarity NPD6908 Approved
0.6053 Remote Similarity NPD6672 Approved
0.6053 Remote Similarity NPD6903 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data